CITED CLIPS
Psilocybin vs. SSRIs
Clinical trials reveal that psilocybin significantly outperforms traditional antidepressants like SSRIs in alleviating depression. As the psychiatric community grapples with the effectiveness and side effects of SSRIs, the unique binding properties of psilocybin to serotonin receptors offer promising insights into mood enhancement and creativity. This exploration into the serotonin 2A receptor highlights the potential of psilocybin to foster neuroplasticity and improve overall well-being.In this clip
From this podcast
Huberman Lab
How Psilocybin Can Rewire Our Brain, Its Therapeutic Benefits & Its Risks | Huberman Lab Podcast
Related Questions
What does Andrew Huberman say about psilocybin?
What has Andrew Huberman said about psychedelics for therapy in the episode Understanding & Conquering Depression | Huberman Lab Podcast #34 and the clip Psilocybin Experiences?
Additionally, what insights can you provide from the episode Dr. Robin Carhart-Harris: The Science of Psychedelics for Mental Health | Huberman Lab Podcast and the clip Psychedelics and the Brain?